Trial Profile
Dupixent Special Drug Use Investigation for long term use
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2022
Price :
$35
*
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sanofi K.K.
- 20 Aug 2020 Status changed from recruiting to active, no longer recruiting.
- 02 Jul 2018 Status changed from not yet recruiting to recruiting.
- 15 Jun 2018 New trial record